Primary Site >> Colorectal Cancer
Gene >> PDGFA
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Expression of several growth factors and their receptor genes in human colon carcinomas. PMID: 1980764 Ref: Growth factors and oncogenes in human gastrointestinal carcinomas. PMID: 2157713 |
Ref: Growth factor mRNA expression in human head and neck malignant tumors. PMID: 7692890 Ref: Dominant-negative mutants of platelet-derived growth factor revert the transformed phenotype of human astrocytoma cells. PMID: 8246942 |
Ref: Differentiation-associated modulation of heparan sulfate structure and function in CaCo-2 colon carcinoma cells. PMID: 9719684 |
Ref: The proteolytic processing of pro-platelet-derived growth factor-A at RRKR(86) by members of the proprotein convertase family is functionally correlated to platelet-derived growth factor-A-induced functions and tumorigenicity. PMID: 12670890 |
Ref: Expression of activated platelet-derived growth factor receptor in stromal cells of human colon carcinomas is associated with metastatic potential. PMID: 16988946 |
Ref: Antiangiogenic effects of ganetespib in colorectal cancer mediated through inhibition of HIF-1alpha and STAT-3. PMID: 23838996 |
Ref: Repression of liver colorectal metastasis by the serpin Spn4A a naturally occurring inhibitor of the constitutive secretory proprotein convertases. PMID: 24961901 |
Ref: Combining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam trial. PMID: 25867261 |
Ref: PITPNC1 Recruits RAB1B to the Golgi Network to Drive Malignant Secretion. PMID: 26977884 |
Ref: Identification of hypoxia-regulated angiogenic genes in colorectal cancer. PMID: 28928094 |
Ref: Prediction of novel target genes and pathways involved in bevacizumab-resistant colorectal cancer. PMID: 29342159 Ref: STAT3 exacerbates survival of cancer stem-like tumorspheres in EGFR-positive colorectal cancers: RNAseq analysis and therapeutic screening. PMID: 30068339 |